Puro Risk Insights Blog

Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.

We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.

From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.

ON THE BLOG

CATEGORIES

FEATURED POST

Recent Industry Updates

All Articles

Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.

Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

South Africa Cannabis Market Is Still Waiting For A Real Commercial Framework

South Africa has demand, operators, and clear cannabis potential, but it still lacks the commercial rules needed to turn legalization into a functioning market. The bigger lesson is that banking access, insurance availability, licensing clarity, and product rules matter just as much as legalization itself.

Read More
Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

Morocco’s Legal Cannabis Industry Moves Into Registered Product Manufacturing

Morocco’s legal cannabis industry now has more than 140 cannabis based products manufactured and officially registered with the Moroccan Agency for Medicines and Health Products. The bigger lesson is that Morocco is moving from cultivation potential into regulated product manufacturing, export readiness, and international supply chain relevance.

Read More
Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

Trulieve NYSE Listing Could Redraw The Cannabis Capital Market Line

Trulieve is expected to become the first U.S. cannabis company listed on a major U.S. stock exchange, with shares set to trade on the NYSE under ticker TRLV. The bigger lesson is that major exchange access may now depend on clean restructuring, medical cannabis positioning, DEA registration readiness, and institutional capital credibility.

Read More
Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

Brazil Medical Cannabis Imports Hit Record High As Demand Grows

Brazil set a new record for medical cannabis imports in March 2026, with more than 61,000 import authorizations granted in the first quarter and 23,199 in March alone. The bigger lesson is that Brazil is becoming a serious medical cannabis growth market, but import dependence, patient authorization rules, and distribution structure will decide who actually captures the opportunity.

Read More
Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

Emblem Cannabis Deal Shows How Distressed Assets Are Reshaping Canada

Emblem Cannabis is set to acquire Ayurcann assets, including vape and pre roll manufacturing capacity, a Health Canada licensed facility, and national distribution relationships. The bigger lesson is that Canadian cannabis consolidation is still being driven by tax pressure, debt, wholesale compression, and distressed asset strategy.

Read More
Business & Economy Puro Risk Editorial Team Business & Economy Puro Risk Editorial Team

New York Medical Cannabis Fees Are Becoming A Market Stress Test

New York medical cannabis operators owe up to $15 million each in conversion fees tied to adult use market access, but falling medical sales and dispensary closures are putting pressure on the fee structure. The bigger lesson is that licensing costs can become serious business risk when revenue, patient access, and capital are weakening.

Read More

Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.

Ready to review your cannabis coverage?

Call us on (323)905-3396
 or growth@cannashield.io